{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T03:32:15Z","timestamp":1648956735963},"reference-count":5,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.2169\/internalmedicine.6952-20","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T22:14:11Z","timestamp":1613340851000},"page":"2521-2521","source":"Crossref","is-referenced-by-count":0,"title":["Reply to \"Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?\""],"prefix":"10.2169","volume":"60","author":[{"given":"Hiroaki","family":"Matsuura","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Omori","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiriko","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Kuribayashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Mitsumune","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Takigawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Shibayama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matsuura H, Fujiwara K, Omori H, et al. Successful treatment with benralizumab for allergic bronchopulmonary aspergillosis that developed after disastrous heavy rainfall in Western Japan. Intern Med 60: 1443-1450, 2021.","DOI":"10.2169\/internalmedicine.6217-20"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Agarwal R, Dhooria S, Sehgal IS, et al. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J 52: 1801159, 2018.","DOI":"10.1183\/13993003.01159-2018"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Agarwal R, Dhooria S, Sehgal IS, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest 153: 656-664, 2018.","DOI":"10.1016\/j.chest.2018.01.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Moreira AS, Silva D, Ferreira AR, Delgado L. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. Clin Exp Allergy 44: 1210-1227, 2014.","DOI":"10.1111\/cea.12333"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chupp G, Lugogo NL, Kline JN, et al. Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma. Ann Allergy Asthma Immunol 122: 478-485, 2019.","DOI":"10.1016\/j.anai.2019.02.016"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/15\/60_6952-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T04:04:53Z","timestamp":1628309093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/15\/60_6952-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":5,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6952-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]},"article-number":"6952-20"}}